NCT05287724View on ClinicalTrials.gov

Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 19, 2022

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
PruritusSkin Disorder
Interventions
DRUG

N-acetyl cysteine

1,500 mg twice daily for seven days

DRUG

Placebo

Placebo taken twice daily for seven days

Trial Locations (1)

45324

Wright State Physicians, Fairborn

All Listed Sponsors
lead

Wright State University

OTHER